Gleevec Label Updated With Cardiovascular Risk Language
This article was originally published in The Pink Sheet Daily
Executive Summary
Letter to physicians notes a small chance for CHF and left ventricular dysfunction with imatinib exists, but patients with or at risk for cardiac disease should be closely monitored.